Washington, DC 20006-5349
HELPLINE
Click here to learn more or to register for the International Symposium on Malignant Mesothelioma.
[youtube=http://www.youtube.com/watch?v=AeaZWg50vKg]
Mental health is a big issue for mesothelioma patients, caregivers, and family members. This session covers how patients as well as their loved ones can
CAR-T (Chimeric antigen receptor) cell therapy is a type of immunotherapy that uses a patient’s T cells to attack cancer cells. T cells are white
For patients with MPM (Malignant Pleural Mesothelioma), the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) as a first-line treatment when combined with
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
